Jaw-Yuan Wang
Overview
Explore the profile of Jaw-Yuan Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
315
Citations
3777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chuang J, Tsai H, Chen P, Huang C, Su W, Chang T, et al.
Kaohsiung J Med Sci
. 2025 Mar;
:e70008.
PMID: 40078099
Neoadjuvant chemoradiotherapy (NACRT) is the standard treatment for patients with locally advanced rectal cancer (LARC). Tumor regression grade (TRG) is an essential prognostic factor in determining treatment efficacy. However, the...
2.
Chen P, Chen C, Chang S, Chang Y, Lin B, Chen H, et al.
Am J Cancer Res
. 2025 Jan;
14(12):5863-5873.
PMID: 39803657
This multicenter study explored the survival benefits of upfront primary tumor resection (PTR) followed by first-line cetuximab plus chemotherapy in real-world patients with wild-type metastatic colorectal cancer (mCRC). Treatment options...
3.
Kianpour M, Huang C, Vejvisithsakul P, Wang J, Chien-Feng L, Shiao M, et al.
Int J Biol Macromol
. 2025 Jan;
293:138914.
PMID: 39756367
No abstract available.
4.
Kianpour M, Huang C, Vejvisithsakul P, Wang J, Li C, Shiao M, et al.
Int J Biol Macromol
. 2025 Jan;
293:138913.
PMID: 39756365
No abstract available.
5.
Chuang J, Chen Y, Wang J
Kaohsiung J Med Sci
. 2024 Dec;
41(2):e12926.
PMID: 39717937
Colorectal cancer is a leading cause of cancer-related morbidity and mortality worldwide, with more than 1.9 million new cases reported in 2020, and is associated with major survival challenges, particularly...
6.
Chen Y, Chang T, Su W, Yeh Y, Chen P, Huang P, et al.
Int J Colorectal Dis
. 2024 Oct;
39(1):171.
PMID: 39453531
Background: Metastatic colorectal cancer (mCRC) poses a clinical challenge and requires a combination of systemic therapy and conversion surgery. Although first-line chemotherapy and targeted therapy are considered the standard treatments...
7.
Chuang J, Tsai H, Su W, Chen P, Huang C, Chang T, et al.
Oncol Res
. 2024 Oct;
32(11):1723-1732.
PMID: 39449806
The pTNM staging system is widely recognized as the most effective prognostic indicator for cancer. The latest update of this staging system introduced a new pathological staging system (ypTNM) for...
8.
Yin T, Chen Y, Su W, Chang T, Chen P, Li C, et al.
Surg Endosc
. 2024 Oct;
38(12):7621-7626.
PMID: 39433589
Background: Intracorporeal anastomosis offers notable advantages over extracorporeal techniques, including reduced tissue manipulation leading to faster recovery and potentially lower risks of surgical site infections and complications. However, it also...
9.
Yeh J, Lin C, Hsiao P, Perng D, Chen J, Hung K, et al.
Endoscopy
. 2024 Feb;
56(7):494-502.
PMID: 38378019
Background: Sessile serrated lesions (SSLs) are obscured lesions predominantly in the right-sided colon and associated with interval colorectal cancer; however, their prevalence and risk factors among younger individuals remain unclear....
10.
Chen C, Chang S, Chang Y, Lin B, Chen H, Hsieh Y, et al.
Am J Cancer Res
. 2024 Jan;
13(12):6333-6345.
PMID: 38187069
This multicenter study aimed to explore the survival benefit of metastasectomy by first-line cetuximab-based chemotherapy in real-world patients with wild-type metastatic colorectal cancer (mCRC). The primary endpoints were overall survival...